SRT Stock Overview
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Sartorius Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €212.50 |
52 Week High | €310.50 |
52 Week Low | €181.00 |
Beta | 0.84 |
1 Month Change | -24.38% |
3 Month Change | -11.27% |
1 Year Change | -25.04% |
3 Year Change | -48.04% |
5 Year Change | 45.55% |
Change since IPO | 19,592.03% |
Recent News & Updates
Recent updates
Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet
Jul 12Why The 23% Return On Capital At Sartorius (ETR:SRT) Should Have Your Attention
Jun 24If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late
Jun 06Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly
Mar 28We Think Sartorius' (ETR:SRT) Robust Earnings Are Conservative
Feb 23Investors Interested In Sartorius Aktiengesellschaft's (ETR:SRT) Earnings
Feb 21If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late
Jan 20Sartorius (ETR:SRT) Is Achieving High Returns On Its Capital
Nov 25Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?
Oct 21Do Sartorius's (ETR:SRT) Earnings Warrant Your Attention?
Aug 29Sartorius (ETR:SRT) Hasn't Managed To Accelerate Its Returns
Aug 12These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well
Jul 06Does Sartorius (ETR:SRT) Deserve A Spot On Your Watchlist?
May 12Sartorius Aktiengesellschaft's (ETR:SRT) CEO Will Probably Have Their Compensation Approved By Shareholders
Mar 20Is Sartorius Aktiengesellschaft's (ETR:SRT) Shareholder Ownership Skewed Towards Insiders?
Feb 22Our Take On The Returns On Capital At Sartorius (ETR:SRT)
Feb 04Here's Why We Think Sartorius (ETR:SRT) Is Well Worth Watching
Jan 13Can Sartorius Aktiengesellschaft (ETR:SRT) Maintain Its Strong Returns?
Dec 24What Type Of Shareholders Make Up Sartorius Aktiengesellschaft's (ETR:SRT) Share Registry?
Nov 18Shareholder Returns
SRT | DE Life Sciences | DE Market | |
---|---|---|---|
7D | -17.6% | -9.3% | -1.5% |
1Y | -25.0% | -11.2% | 0.9% |
Return vs Industry: SRT underperformed the German Life Sciences industry which returned -11.2% over the past year.
Return vs Market: SRT underperformed the German Market which returned 0.9% over the past year.
Price Volatility
SRT volatility | |
---|---|
SRT Average Weekly Movement | 6.8% |
Life Sciences Industry Average Movement | 6.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: SRT's share price has been volatile over the past 3 months.
Volatility Over Time: SRT's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1870 | 14,614 | Joachim Kreuzburg | www.sartorius.com |
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products.
Sartorius Aktiengesellschaft Fundamentals Summary
SRT fundamental statistics | |
---|---|
Market cap | €16.73b |
Earnings (TTM) | €148.80m |
Revenue (TTM) | €3.31b |
126.0x
P/E Ratio5.7x
P/S RatioIs SRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SRT income statement (TTM) | |
---|---|
Revenue | €3.31b |
Cost of Revenue | €1.80b |
Gross Profit | €1.51b |
Other Expenses | €1.36b |
Earnings | €148.80m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 19, 2024
Earnings per share (EPS) | 2.16 |
Gross Margin | 45.55% |
Net Profit Margin | 4.49% |
Debt/Equity Ratio | 134.4% |
How did SRT perform over the long term?
See historical performance and comparison